Amanote Research
Register
Sign In
2019 Appendix Edition: Hemostatic Treatment Guidelines for Hemophilia Patients the Use of Hemlibra® (Emicizumab)
Japanese Journal of Thrombosis and Hemostasis
doi 10.2491/jjsth.31.93
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2020
Authors
Unknown
Publisher
Japanese Society on Thrombosis and Hemostasis
Related search
Psy155 - Determining the Value of Emicizumab (Hemlibra®) for the Prophylaxis Treatment of Haemophilia a Patients With Inhibitors in Spain by Multi-Criteria Decision Analysis (Mcda)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Guidelines to the Practice of Anesthesia – Revised Edition 2019
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Kovaltry® for the Replacement Therapy in Patients With Hemophilia A
Farmeconomia. Health economics and therapeutic pathways
Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy42 - Exploring the Potential Budget Impact of Emicizumab for Hemophilia a With Inhibitor in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Biodiesel Handling and Use Guidelines (Second Edition)
2019 CAP Treatment Guidelines – The Need for a Change Towards a More Parsimonious Antibiotic Use?
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
The Use of a Globulin Substance Derived From Beef Plasma as a Local Hemostatic in Hemophilia 12
Journal of Clinical Investigation
Medicine
Reply To: 2019 CAP Treatment Guidelines – The Need for a Change Towards a More Parsimonious Antibiotic Use?
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
